Metabolic factors associated with plasma phosphorylated tau analytes used to detect Alzheimers disease pathology
Yang, K. L.; Ma, Y.; Ennis, G.; Jonaitis, E. M.; Rea Reyes, R. E.; Johnson, S. C.; Ashton, N. J.; Blennow, K.; Zetterberg, H.; Bendlin, B. B.
Show abstract
STRUCTURED ABSTRACTO_ST_ABSINTRODUCTIONC_ST_ABSThe interpretation of plasma phosphorylated tau (pTau) levels may be influenced by metabolic conditions, such as insulin resistance (IR), type 2 diabetes mellitus (T2DM), obesity, and kidney function. We examined the extent to which metabolic factors are associated with plasma pTau concentrations (pTau181, pTau217, pTau231) and the contribution of these factors on analytical outcomes. METHODSWe analyzed data from 287 participants using partial Spearmans rho, Mann Whitney U, ROC analysis, and linear mixed models. RESULTSConcordance between plasma pTau217 and amyloid PET was not influenced by IR or estimated-glomerular-filtration-rate (eGFR). Accounting for eGFR improved concordance of pTau181 and pTau231 with amyloid PET. Age, binarized waist-to-hip ratio, and amyloid status were associated with all longitudinal pTau concentrations, and eGFR associated with longitudinal pTau231. DISCUSSIONMetabolic health may influence the interpretation of some plasma pTau biomarkers, potentially necessitating adjustments for metabolic factors in research and clinical settings.
Matching journals
The top 2 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Understanding the interrelationships of type-2 diabetes and hypertension with brain and cognitive health: a UK Biobank study 91%
- Effects of Dipeptidyl Peptidase-4 Inhibitors and Sulfonylureas on Cognitive and Physical Function in Nursing Home Residents 89%
- Hepatic and abdominal adiposity in type 2 diabetes as assessed with machine learning on CT scans 89%
Similar papers in this journal
Similar papers in this journal
- A conformational variant of p53 (U-p53 AZ ) as blood-based biomarker for the prediction of the onset of symptomatic Alzheimer’s disease 93%
- Continuous Associations Between Remote Self-Administered Cognitive Measures and Imaging Biomarkers of Alzheimer’s Disease 93%
- Plasma brain-derived p-tau217 outperforms other p-tau species in detecting abnormal brain amyloid in an Asian cohort of older people with cerebrovascular disease burden 93%